Flavonoid pharmacokinetics : methods of analysis, preclinical and clinical pharmacokinetics, safety, and toxicology / (Record no. 206265)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 05661cam a2200589Mi 4500 |
| 001 - CONTROL NUMBER | |
| control field | ocn818819707 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20171113091707.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu---unuuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 121120s2013 xx o 000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781118468524 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 111846852X |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781118354391 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1118354397 |
| Qualifying information | (electronic bk.) |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | AU@ |
| System control number | 000050207302 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | AU@ |
| System control number | 000050635844 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | DEBBG |
| System control number | BV041048987 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | NZ1 |
| System control number | 15915309 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | DEBBG |
| System control number | BV043395199 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)818819707 |
| Canceled/invalid control number | (OCoLC)819514468 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | EBLCP |
| Language of cataloging | eng |
| Description conventions | pn |
| Transcribing agency | EBLCP |
| Modifying agency | N$T |
| -- | UIU |
| -- | OCLCQ |
| -- | DG1 |
| -- | OCLCF |
| -- | OCLCQ |
| -- | DEBBG |
| -- | D6H |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | MAIN |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | QK898.F5 |
| Item number | F53 2013eb |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 071000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.7 |
| 245 00 - TITLE STATEMENT | |
| Title | Flavonoid pharmacokinetics : methods of analysis, preclinical and clinical pharmacokinetics, safety, and toxicology / |
| Statement of responsibility, etc. | edited by Neal M. Davies, Jaime A. Yáñez. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc. | Chicester : |
| Name of publisher, distributor, etc. | Wiley, |
| Date of publication, distribution, etc. | 2013. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (356 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 500 ## - GENERAL NOTE | |
| General note | 6.3 Flavonoids and Hepatic Side Effects. |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Title page; Copyright page; Dedication; Contents; Foreword; Preface; Contributors; 1: Polyphenols and Flavonoids: An Overview; 1.1 Introduction; 1.2 Synthesis; 1.2.1 Synthesis of Flavonoids; 1.3 Sources; 1.4 Pharmacological Activities of Selected Flavonoids; 1.4.1 Hesperidin and Hesperetin; 1.4.2 Naringin and Naringenin; 1.4.3 Eriocitrin and Eriodictyol; 1.4.4 Phloretin; 1.4.5 Homoeriodictyol; 1.4.6 Isosakuranetin; 1.4.7 Taxifolin; 1.4.8 Sakuranetin; 1.4.9 Gallic Acid; 1.5 Conclusions; References; 2: Analysis of Flavonoids through Chromatography; 2.1 Introduction; 2.2 Polyphenols. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 2.3 Chromatography2.3.1 Chromatographic Techniques; 2.3.2 Affinity Chromatography; 2.3.3 Ion-Exchange Chromatography; 2.3.4 Partition (Absorption); 2.3.5 Adsorption; 2.3.6 Paired Chromatography; 2.4 Detection; 2.4.1 Ultraviolet-Visible/Photodiode Array Detection; 2.4.2 Fluorescence Detection; 2.4.3 Mass Spectrometry; 2.4.4 Nuclear Magnetic Resonance; 2.4.5 Other Methods and Techniques; 2.5 Method Development; 2.5.1 Physicochemical Properties; 2.5.2 Mobile Phase; 2.5.3 Stationary Phase; 2.5.4 Internal and External Standards; 2.5.5 Processing; 2.6 Validation; 2.6.1 Peak Shape and Distribution. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 2.6.2 Selectivity, Sensitivity, Accuracy, Precision, and Recovery2.6.3 Stability; 2.7 Summary; 2.8 Future Directions; 2.9 Conclusions; References; 3: Chiral Methods of Flavonoid Analysis; 3.1 Introduction; 3.2 Flavonoids and Chirality; 3.3 Separation of Enantiomers through Chromatography; 3.3.1 Chiral Stationary Phases (CSP) as Direct Methods; 3.3.2 Chiral Derivatization Techniques and Indirect Analysis; 3.4 Enantiomerization and Racemization; 3.5 Current Methods: Pros and Cons; 3.6 Flavanones; 3.6.1 Eriocitrin and Eriodictyol; 3.6.2 Flavanone; 3.6.3 Hesperidin and Hesperetin. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 3.6.4 Homoeriodictyol3.6.5 Isosakuranetin; 3.6.6 Liquiritigenin; 3.6.7 Naringin and Naringenin; 3.6.8 Narirutin; 3.6.9 Neoeriocitrin; 3.6.10 Neohesperidin; 3.6.11 Pinocembrin; 3.6.12 Pinostrobin; 3.6.13 Prunin; 3.6.14 Sakuranetin; 3.6.15 Taxifolin; 3.6.16 6-Prenylnaringenin, 8-Prenylnaringenin, and Isoxanthohumol; 3.7 Catechins; 3.7.1 Catechin; 3.7.2 Catechin Gallate; 3.7.3 Epicatechin; 3.7.4 Epicatechin Gallate; 3.7.5 Epigallocatechin; 3.7.6 Epigallocatechin Gallate; 3.7.7 Gallocatechin; 3.8 Conclusions; References; 4: Preclinical Pharmacokinetics of Flavonoids; 4.1 Introduction. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 4.2 Absorption4.3 Distribution; 4.4 Metabolism; 4.5 Excretion; 4.6 Conclusions; References; 5: Clinical Pharmacokinetics of Flavonoids; 5.1 Introduction; 5.2 Methods of Analysis; 5.3 Flavonoid Pharmacokinetics; 5.3.1 Nonchiral Flavonoids; 5.3.2 Chiral Flavonoids; 5.3.3 Flavonoid Derivatives; 5.4 Drug Interactions; 5.4.1 Effects of Flavonoids on Other Drug Pharmacokinetics; 5.4.2 Effects of Other Drugs on Flavonoid Pharmacokinetics; 5.5 Conclusions; References; 6: Toxicology and Safety of Flavonoids; 6.1 Introduction; 6.2 Flavonoids and the Gastrointestinal Tract; 6.2.1 Diarrhea; 6.2.2 Colitis. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Highlighting the extremely important preclinical aspects of flavonoids, including pharmacokinetics and analysis in biological samples, Flavonoid Pharmacokinetics covers the methods of analysis and pharmacokinetics (preclinical and clinical) of flavonoids to help readers comprehend pharmacokinetic terminology, understand the large number of compounds that encompass the flavonoid family, appreciate the multiple analytical methods available, and assess preclinical and clinical pharmacokinetics of flavonoids and similar chemical-derived compounds. The book uses applicable examples in differ. |
| 588 0# - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Print version record. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Flavonoids. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Pharmacokinetics. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL |
| General subdivision | Pharmacology. |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Flavonoids. |
| Source of heading or term | fast |
| Authority record control number | (OCoLC)fst00927101 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Pharmacokinetics. |
| Source of heading or term | fast |
| Authority record control number | (OCoLC)fst01060250 |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Davies, Neal M. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yáñez, Jaime A. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Davies, Neal M. |
| Title | Flavonoid Pharmacokinetics : Methods of Analysis, Preclinical and Clinical Pharmacokinetics, Safety, and Toxicology. |
| Place, publisher, and date of publication | Chicester : Wiley, ©2012 |
| International Standard Book Number | 9780470578711 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://onlinelibrary.wiley.com/book/10.1002/9781118468524 |
| Public note | Wiley Online Library |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | |
| Koha item type | Books |
No items available.